ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

O’Neill Account, Kennedy Hearing, Create Climate On Capitol Hill for Increasing Cancer Funding

May 3, 1991

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008

Hopkins Challenges Litton For Research Contract At FCRF

April 16, 1982

NCI Seeks CRADA Partners To Develop Targets Drugs

October 24, 1997

NCI is developing review criteria for a Cancer Center Loan Program that would provide $200 million in loans for capital improvements to qualified centers. NCAB member Eric Lander criticizes limited discussion, “lack of vision” for the loan program.

June 18, 2004

Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists.

March 2, 2007